Open AccessState of the Art: Toward Improving Outcomes of Lung and Liver Tumor Biopsies in Clinical Trials—A Multidisciplinary Approach
Author(s) -
Elliot Levy,
Maria Isabel Fiel,
Stanley R. Hamilton,
David E. Kleiner,
Shan J. McCall,
Peter Schirmacher,
William D. Travis,
Michael Kuo,
Robert D. Suh,
Alda L. Tam,
Shaheen Islam,
Katherine V. Ferry-Galow,
Rebecca A. Enos,
James H. Doroshow,
Hala R. Makhlouf
Publication year - 2020
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.19.02322
Subject(s) - medicine , medical physics , guideline , multidisciplinary approach , biopsy , clinical trial , best practice , multidisciplinary team , pathology , nursing , social science , management , sociology , economics
National Cancer Institute (NCI)-sponsored clinical trial network studies frequently require biopsy specimens for pharmacodynamic and molecular biomarker analyses, including paired pre- and post-treatment samples. The purpose of this meeting of NCI-sponsored investigators was to identify local institutional standard procedures found to ensure quantitative and qualitative specimen adequacy.